These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29643415)

  • 1. Proteomic profiling of human cancer pseudopodia for the identification of anti-metastatic drug candidates.
    Choi S; Bhagwat AM; Al Mismar R; Goswami N; Ben Hamidane H; Sun L; Graumann J
    Sci Rep; 2018 Apr; 8(1):5858. PubMed ID: 29643415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells.
    Shankar J; Messenberg A; Chan J; Underhill TM; Foster LJ; Nabi IR
    Cancer Res; 2010 May; 70(9):3780-90. PubMed ID: 20388789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anticancer phytochemical rocaglamide inhibits Rho GTPase activity and cancer cell migration.
    Becker MS; Müller PM; Bajorat J; Schroeder A; Giaisi M; Amin E; Ahmadian MR; Rocks O; Köhler R; Krammer PH; Li-Weber M
    Oncotarget; 2016 Aug; 7(32):51908-51921. PubMed ID: 27340868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SORBS1 suppresses tumor metastasis and improves the sensitivity of cancer to chemotherapy drug.
    Song L; Chang R; Dai C; Wu Y; Guo J; Qi M; Zhou W; Zhan L
    Oncotarget; 2017 Feb; 8(6):9108-9122. PubMed ID: 27791200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for pseudopodia purification and proteomic analysis.
    Wang Y; Ding SJ; Wang W; Yang F; Jacobs JM; Camp D; Smith RD; Klemke RL
    Sci STKE; 2007 Aug; 2007(400):pl4. PubMed ID: 17712138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and target identification of bioactive compounds that modulate cell migration and autophagy.
    Tashiro E; Imoto M
    Bioorg Med Chem; 2016 Aug; 24(15):3283-90. PubMed ID: 27094149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
    Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudopodial and β-arrestin-interacting proteomes from migrating breast cancer cells upon PAR2 activation.
    Parisis N; Metodieva G; Metodiev MV
    J Proteomics; 2013 Mar; 80():91-106. PubMed ID: 23313222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
    Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
    Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology.
    Zheng P; Wang Q; Teng J; Chen J
    Pharmacol Res; 2015 Sep; 99():11-5. PubMed ID: 25976680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New challenges in pseudopodial proteomics by a laser-assisted cell etching technique.
    Mimae T; Ito A
    Biochim Biophys Acta; 2015 Jun; 1854(6):538-46. PubMed ID: 25461796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling.
    Cheng C; Ji Z; Sheng Y; Wang J; Sun Y; Zhao H; Li X; Wang X; He Y; Yao J; Wang L; Zhang C; Guo Y; Zhang J; Gao WQ; Zhu HH
    Theranostics; 2018; 8(17):4633-4648. PubMed ID: 30279728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of artonin e on migration and invasion capabilities of human lung cancer cells.
    Plaibua K; Pongrakhananon V; Chunhacha P; Sritularak B; Chanvorachote P
    Anticancer Res; 2013 Aug; 33(8):3079-88. PubMed ID: 23898063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.
    Wang D; Chuang HC; Weng SC; Huang PH; Hsieh HY; Kulp SK; Chen CS
    J Med Chem; 2009 Sep; 52(18):5642-8. PubMed ID: 19708661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MS/MS-based strategies for proteomic profiling of invasive cell structures.
    Havrylov S; Park M
    Proteomics; 2015 Jan; 15(2-3):272-86. PubMed ID: 25303514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer.
    Yokotsuka M; Iwaya K; Saito T; Pandiella A; Tsuboi R; Kohno N; Matsubara O; Mukai K
    Breast Cancer Res Treat; 2011 Apr; 126(2):311-8. PubMed ID: 20419393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targets for anti-metastatic drug development.
    Stock AM; Troost G; Niggemann B; Zänker KS; Entschladen F
    Curr Pharm Des; 2013; 19(28):5127-34. PubMed ID: 23607665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.
    Zhao H; Jiao Y; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(12):15582-90. PubMed ID: 26884827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
    Park SY; Kim YH; Kim Y; Lee SJ
    Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors for metastasis development.
    Lang K; Drell TL; Zaenker KS; Entschladen F
    Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):69-80. PubMed ID: 18221027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.